...microplate strip washer for 96- and 384-well plate...trip washing capability, the Columbus combines hig...of operation. , Features ,Key features of the...s, crosswise aspiration, overflow and bottom washi...
...rotein Interaction Reagent A powerful new method ...n as an in vitro method for protein interaction di...the exclusive Pierce ProFound Sulfo-SBED Biotin La...relating to protein interactions. • The u...
...d stackable multi-function incubator. It uses a mi...n to accurately control temperature and agitation ... temperature in the incubator. Temperature can be ...er. Built in maintenance-free stepping motor for h...
Human siTrio from B-Bridge International
Biology Products:(Date:11/19/2009)... A team led by Penn State,s Ross Hardison, T. Min...ogy, has taken a large step toward unraveling how ... products during development and growth. Working w...d Gerd Blobel at Children,s Hospital of Philadelph...ss of producing red blood cells (erythrocytes). Th...
(Date:11/19/2009)... , Arnie Miller, University of Cincinnati profess... & Sciences, and co-author Michael Foote of the Un...Nov. 20 issue of Science with their paper, "Epic...netics of Mass Extinction and Origination." , Fo...ed in the history of biodiversity have focused on ...
(Date:11/19/2009)... CHAMPAIGN, Ill. A new statistical technique dev...s allows scientists to scan a genome for specific ...owledge of the relevant transcription factors. The...th the mouse genome and the fruit fly genome. , "... than other approaches, and is especially useful f...
Breaking Biology News(10 mins):New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 4Technique finds gene regulatory sites without knowledge of regulators 2Caraco Pharmaceutical Laboratories Ltd Announces an Indefinite Reduction in its Workforce 50752 1Caraco Pharmaceutical Laboratories Ltd Announces an Indefinite Reduction in its Workforce 50752 2avVaa World Health Care Products Inc Signs Agreement with 3PL Worldwide Inc for Order Management 26 Fulfillment for avVaas Product 12896 1avVaa World Health Care Products Inc Signs Agreement with 3PL Worldwide Inc for Order Management 26 Fulfillment for avVaas Product 12896 2Kids of Parents Who Value Exercise Are More Active 50751 1Kids of Parents Who Value Exercise Are More Active 50751 2(Date:11/19/2009)... and WALTHAM, Mass., Nov. 19 Arlin...s find that the leading driver of antibiotic selec...ectrum activity against gram-positive and gram-neg...hat can cause nosocomial pneumonia, surveyed Europ... agents that provide appropriate coverage against ...
(Date:11/19/2009)...9 /PRNewswire/ - Aegera Therapeutics Inc. announce...mized Phase 2B study of AEG35156, a targeted antis...iple oncology indications. ,, The study, entitl...X-Linked Inhibitor of Apoptosis (XIAP) Antisense A...bine and Idarubicin in AML Following Failure of a ...
(Date:11/19/2009)...orld,s Top Gene Synthesis Companies Form Internati...e Best Practices in Risk Reduction ,Five Member ...ynthesis Capacity , (PRWE...leading gene synthesis companies today announced a...rotocol to promote biosecurity in the gene synthes...
(Date:11/19/2009)...Austria, November 19 AFFiRiS AG wi...oduct candidate at an unexpectedly early,stage of ... to enter into,Phase II clinical trial early in 20...ws the completion of two Phase I trials with the c...t decision on the first interim,analysis of the se...
Breaking Biology Technology:Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3